million

Longeveron Announces Up To $17.5 Million Public Offering

MIAMI, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage regenerative medicine biotechnology…

5 months ago

Genius Group executes buyback of one million shares as part of approved 20% share buyback mandate

SINGAPORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading…

5 months ago

OCI Confirms Q3 2025 USD 700 Million Extraordinary Cash Distribution

AMSTERDAM, Aug. 4, 2025 /PRNewswire/ -- OCI Global (Euronext: OCI), ("OCI," the "Company") announces today that it will pay a USD…

5 months ago

WEEX Burns $2 Million WXT, 0.61% of the Total Supply

VICTORIA, Seychelles, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WEEX, a leading cryptocurrency exchange successfully completed its second-quarter burn of WEEX…

5 months ago

Skipper Delivers Record Q1 Results with Rs. 12,539 Million Revenue and All-Time High Order Book of Rs. 85,205 Million

Business Highlights Company registered its highest-ever first quarter revenue of Rs. 12,539 million on back of strong execution in Engineering…

5 months ago

Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds

Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage…

5 months ago

MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million

July 31, 2025 19:30 ET  | Source: MediciNova, Inc. LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc.,…

5 months ago

NYSE Content Advisory: Pre-market update + Ambiq raises $96 million in IPO

NEW YORK, July 30, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

5 months ago

AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering

OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the “Company”), today announced the pricing…

6 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company…

6 months ago